Related Experiment Video
Updated: Jul 13, 2026
04:28
Warm Moxibustion and Scraping as a Traditional Chinese Medicine Therapy for Cervical Spondylosis Treatment
Published on: June 27, 2025
WITHDRAWN: Physical medicine modalities for mechanical neck disorders
A R Gross1, P D Aker, C H Goldsmith
1McMaster University, School of Rehabilitation Science, IAHS, Room 440, 1400 Main Street West, 4th Fl, Hamilton, Ontario, Canada, L8S 1C7. grossa@mcmaster.ca
The Cochrane Database of Systematic Reviews
|July 20, 2007
Summary
Electromagnetic therapy may effectively reduce neck pain, while laser therapy shows no significant benefit. More research is needed for other physical medicine modalities in treating mechanical neck disorders.
Area of Science:
- Orthopedics
- Physical Medicine and Rehabilitation
- Pain Management
Background:
- Neck pain is a prevalent condition affecting a significant portion of the adult population.
- Diverse treatment approaches exist for neck pain, with varying perceived benefits.
- There is a growing demand for evidence-based practices in healthcare for neck pain management.
Purpose of the Study:
- To systematically review the efficacy of physical medicine modalities for treating mechanical neck disorders.
- To assess the effects of these therapies on pain reduction in adults.
Main Methods:
- A systematic review of randomized and controlled trials was conducted.
- Searches included multiple databases (Medline, Embase, etc.) from 1985 to 1993.
- Trial quality was independently assessed, and data extracted by multiple reviewers.
Main Results:
- Thirteen trials of generally good quality were included in the review.
- Electromagnetic therapy demonstrated a significant reduction in neck pain (p <0.01).
- Laser therapy showed no significant difference compared to placebo (p=0.20).
Conclusions:
- Limited evidence supports the use of most physical medicine modalities for mechanical neck pain.
- Electromagnetic therapy shows promise for pain reduction.
- Further research is required to establish the effectiveness of other modalities like exercise, traction, and heat/cold applications.
Related Concept Videos
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:28Classification of Skeletal Muscle Relaxants
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
01:09Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:24Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
01:29Spasmolytic Agents: Chemical Classification
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...